SCHEMBL17065824

SCHEMBL17065824

COc1ccc2c(N(C)Cc3ccccc3)c(Br)ccc2c1

nearest known ligand 0.48

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CALM1 P0DP23 1/20 0.43
CAMKK2 Q96RR4 1/20 0.43
DYRK1A Q13627 2/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
CLK1 P49759 1/20 0.43
MAPK1 P28482 2/20 0.42
TSHR P16473 2/20 0.42
CYP1A2 P05177 1/20 0.41
CYP2A6 P11509 1/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
ACHE P22303 4/20 0.41
BCHE P06276 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17065819 0.81 KMT2A (0.47) MEN1KMT2ATSHRCYP1A2NPC1
SCHEMBL17065837 0.75 CRHR1 (0.42) MEN1KMT2ACLK1MAPK1CYP1A2
SCHEMBL17065826 0.74 KDM4E (0.43) RXFP1ACHEBCHE
SCHEMBL13728488 0.72 ERAP1 (0.51) DYRK1AMEN1KMT2ARXFP1CLK1
SCHEMBL13729795 0.72 SMN1; SMN2 (0.50) CALM1CAMKK2DYRK1AMEN1KMT2A
SCHEMBL1359254 0.68 MAOB (0.50) CYP1A2CYP2A6
SCHEMBL9939707 0.68 ALOX5 (0.56) MEN1KMT2ANPC1RAB9AACHE
SCHEMBL11680743 0.68 TSHR (0.50) CALM1CAMKK2MAPK1TSHR
SCHEMBL15266968 0.68 CYP1A2 (0.48) DYRK1AMEN1KMT2ACLK1CYP1A2
SCHEMBL14266667 0.68 TSHR (0.57) MAPK1TSHRACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3113768-A1 USE OF ARYLALKANOLAMINES AS SIGMA-1 RECEPTOR ANTAGONISTS Universita' Degli Studi Di Pavia (IT) 2017-01-11 EP disclosed
WO-2015132733-A1 USE OF ARYLALKANOLAMINES AS SIGMA-1 RECEPTOR ANTAGONISTS UNIVERSITA' DEGLI STUDI DI PAVIA (IT) 2015-09-11 WO disclosed